Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Cardiff Oncology, Inc. (CRDF)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
19 Dec 2023
PACE GARY W
Director
Cardiff Oncology, Inc.
(CRDF)
697,761
+4%
30,000
$1.37
$41,100.00
BUY
19 Sep 2022
White Lale
Director
Cardiff Oncology, Inc.
(CRDF)
113,788
+15%
15,000
$1.64
$24,525.00
BUY
16 Sep 2022
Levine James E.
Chief Financial Officer, Officer
Cardiff Oncology, Inc.
(CRDF)
60,000
+100%
30,000
$1.56
$46,710.00
BUY
16 Sep 2022
Armitage James O
Director
Cardiff Oncology, Inc.
(CRDF)
13,000
+100%
13,000
$1.56
$20,233.20
BUY
15 Sep 2022
TANNENBAUM RENEE P
Director
Cardiff Oncology, Inc.
(CRDF)
6,400
+277%
10,000
$1.72
$17,168.00
BUY
15 Sep 2022
PACE GARY W
Director
Cardiff Oncology, Inc.
(CRDF)
644,811
+30%
150,000
$1.71
$256,500.00
BUY
21 Sep 2021
PACE GARY W
Director
Cardiff Oncology, Inc.
(CRDF)
494,811
+6%
30,000
$6.75
$202,500.00
BUY
10 Sep 2021
Levine James E.
Chief Financial Officer, Officer
Cardiff Oncology, Inc.
(CRDF)
5,000
+120%
30,000
$6.47
$194,000.00
BUY
26 Mar 2021
Markin Rodney S
Director
Cardiff Oncology, Inc.
(CRDF)
23,879
+13%
2,900
$10.32
$29,933.22
BUY
23 Mar 2021
Kelemen Vicki
Exec. VP and COO, Officer
Cardiff Oncology, Inc.
(CRDF)
6,053
+18%
960
$10.31
$9,897.60
BUY
23 Mar 2021
JACOB GARY S
Director
Cardiff Oncology, Inc.
(CRDF)
21,452
+12%
2,370
$10.42
$24,689.35
BUY
23 Mar 2021
PACE GARY W
Director
Cardiff Oncology, Inc.
(CRDF)
459,811
+2%
10,000
$10.23
$102,300.00
BUY
23 Mar 2021
Erlander Mark
Chief Executive Officer, Officer
Cardiff Oncology, Inc.
(CRDF)
14,481
+7%
965
$10.34
$9,979.74
BUY
22 Mar 2021
BRANCACCIO JOHN P
Director
Cardiff Oncology, Inc.
(CRDF)
12,260
+32%
3,000
$10.95
$32,850.00
BUY
19 Mar 2021
Armitage James O
Director
Cardiff Oncology, Inc.
(CRDF)
14,490
+38%
4,000
$10.82
$43,271.20
BUY
18 Mar 2021
PACE GARY W
Director
Cardiff Oncology, Inc.
(CRDF)
452,811
+0%
3,000
$10.55
$31,660.00
BUY
4 Mar 2021
PACE GARY W
Director
Cardiff Oncology, Inc.
(CRDF)
451,811
+0%
1,500
$9.27
$13,897.50
SELL
23 Nov 2020
Kelemen Vicki
Exec. VP and COO, Officer
Cardiff Oncology, Inc.
(CRDF)
5,054
-87%
35,321
$18.60
$657,020.06
BUY
16 Sep 2020
PACE GARY W
Director
Cardiff Oncology, Inc.
(CRDF)
449,461
+0%
2,550
$5.70
$14,526.50
BUY
14 May 2020
White Lale
Director
Cardiff Oncology, Inc.
(CRDF)
69,930
+100%
69,930
$1.43
$99,999.90
BUY
14 May 2020
JACOB GARY S
Director
Cardiff Oncology, Inc.
(CRDF)
19,552
+844%
17,483
$1.43
$25,000.69
BUY
14 May 2020
Markin Rodney S
Director
Cardiff Oncology, Inc.
(CRDF)
28,160
+292%
20,979
$1.43
$29,999.97
BUY
14 May 2020
BRANCACCIO JOHN P
Director
Cardiff Oncology, Inc.
(CRDF)
9,260
+308%
6,993
$1.43
$9,999.99
BUY
14 May 2020
Erlander Mark
Chief Executive Officer, Officer
Cardiff Oncology, Inc.
(CRDF)
13,369
+109%
6,993
$1.43
$9,999.99
BUY
14 May 2020
Armitage James O
Director
Cardiff Oncology, Inc.
(CRDF)
10,490
+100%
10,490
$1.43
$15,000.70
BUY
14 May 2020
ADAMS THOMAS PHD
Director
Cardiff Oncology, Inc.
(CRDF)
18,875
+286%
13,986
$1.43
$19,999.98
BUY
11 May 2020
PACE GARY W
Director
Cardiff Oncology, Inc.
(CRDF)
447,761
+100%
447,761
$1.34
$599,999.75
BUY
20 Jun 2018
Markin Rodney S
Director
Trovagene, Inc.
(TROV)
63,810
+12%
6,866.667
$5.10
$35,020.00
BUY
8 Jun 2018
Tennant Stanley
Director
Trovagene, Inc.
(TROV)
236,061
+0%
1,666.667
$4.80
$8,000.00
BUY
8 Jun 2018
BRANCACCIO JOHN P
Director
Trovagene, Inc.
(TROV)
53,167
+3%
1,666.667
$4.80
$8,000.00
SELL
5 Sep 2017
Tennant Stanley
Director
Trovagene, Inc.
(TROV)
209,394
-0%
115.75
$49.68
$5,750.46
BUY
19 Dec 2016
Tennant Stanley
Director
Trovagene, Inc.
(TROV)
217,728
+0%
138.889
$151.20
$21,000.00
BUY
16 Dec 2016
WELCH WILLIAM J
CEO, Director, Officer
Trovagene, Inc.
(TROV)
2,500
+2%
65.972
$150.72
$9,943.50
BUY
16 Dec 2016
Tennant Stanley
Director
Trovagene, Inc.
(TROV)
207,728
+0%
207.861
$144.00
$29,932.00
BUY
14 Dec 2016
Erlander Mark
Chief Scientific Officer, Officer
Trovagene, Inc.
(TROV)
5,000
+1%
69.444
$149.40
$10,375.00
SELL
11 Nov 2016
BRIDGER MANAGEMENT, LLC
Former 10% Owner
Trovagene, Inc.
(TROV)
2,968,115
-0%
4,478.778
$221.76
$993,213.75
Home